ASX-listed and Wellington-based medical device software company Volpara Health Technologies is looking to further expand its US market.
The imaging software uses artificial intelligence to aid in the early detection of breast cancer, and is considered the world-leading analyser of fibroglandular
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
